Three-injection intralymphatic immunotherapy in adolescents and young adults with grass pollen rhinoconjunctivitis

Annals of Allergy, Asthma and Immunology

Volumn 116, Issue 2, 2016, Pages 168-170

  Patterson, Amber M ^a,b   Bonny, Andrea E ^a,b   Shiels, William E ^a,b   Erwin, Elizabeth A ^a,b  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRASS POLLEN EXTRACT; PLACEBO; ALLERGEN;

ADOLESCENT; ADULT; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG SAFETY; HUMAN; IMMUNOTHERAPY; INJECTION SITE REACTION; LETTER; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PHLEUM PRATENSE; PILOT STUDY; POLLEN ALLERGY; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; UNITED STATES; URTICARIA; YOUNG ADULT; CONJUNCTIVITIS, ALLERGIC; DESENSITIZATION; ECHOGRAPHY; IMMUNOLOGY; INTRALYMPHATIC DRUG ADMINISTRATION; LYMPH NODE; POACEAE; POLLEN; PROCEDURES; RHINITIS, ALLERGIC, SEASONAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ALLERGENS; CONJUNCTIVITIS, ALLERGIC; DESENSITIZATION, IMMUNOLOGIC; DOUBLE-BLIND METHOD; HUMANS; INJECTIONS, INTRALYMPHATIC; LYMPH NODES; POACEAE; POLLEN; RHINITIS, ALLERGIC, SEASONAL; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84957838376     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2015.11.010     Document Type: Article

References (10)

1. Centers for Disease Control and Prevention, National Center for Health Statistics. FastStats: Allergies and Hay Fever. http://www.cdc.gov/nchs/fastats/allergies.htm. Accessed April 28, 2015.
2. R.N. Ross, H.S. Nelson, and I. Finegold Effectiveness of specific immunotherapy in the treatment of allergic rhinitis: an analysis of randomized, prospective, single- or double-blind, placebo-controlled studies Clin Ther 22 2000 342 350
3. S.R. Durham, S.M. Walker, E.M. Varga, and et al. Long-term clinical efficacy of grass-pollen immunotherapy N Engl J Med 341 1999 468 475
4. L. Jacobsen Preventive aspects of immunotherapy: prevention for children at risk of developing asthma Ann Allergy Asthma Immunol 87 2001 43 46
5. A. Des Roches, L. Paradis, J.L. Menardo, S. Bouges, J.P. Daures, and J. Bousquet Immunotherapy with a standardized Dermatophagoides pteronyssinus extract, VI: specific immunotherapy prevents the onset of new sensitizations in children J Allergy Clin Immunol 99 1997 450 453
6. T. Hylander, L. Latif, U. Petersson-Westin, and L.O. Cardell Intralymphatic allergen-specific immunotherapy: an effective and safe alternative treatment route for pollen-induced allergic rhinitis J Allergy Clin Immunol 131 2013 412 420
7. G. Senti, R. Crameri, D. Kuster, and et al. Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections J Allergy Clin Immunol 129 2012 1290 1296
8. G. Senti, B.M. Prinz Vavricka, I. Erdmann, and et al. Intralymphatic allergen administration renders specific immunotherapy faster and safer: a randomized controlled trial Proc Natl Acad Sci U S A 105 2008 17908 17912
9. M. Witten, H.J. Malling, L. Blom, B.C. Poulsen, and L.K. Poulsen Is intralymphatic immunotherapy ready for clinical use in patients with grass pollen allergy? J Allergy Clin Immunol 132 2013 1248 1252.e5
10. M. Blaiss, J. Maloney, H. Nolte, S. Gawchik, R. Yao, and D.P. Skoner Efficacy and safety of timothy grass allergy immunotherapy tablets in North American children and adolescents J Allergy Clin Immunol 127 2011 64 71